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Predicting clinically signficant change in an inpatient program for people with
severe mental illness
Abstract
Objective: The first aim of this study was to assess the proportion of patients who achieved reliable and
clinically significant change over the course of treatment in an inpatient psychosocial rehabilitation
program. The second aim was to determine whether age, gender, length of stay, and diagnosis and comorbid diagnosis predicted those who were classified as improved or not improved, using clinical
significance criteria. Method: Three hundred and thirty-seven patients from inpatient units at Bloomfield
Hospital, Orange, New South Wales, Australia were assessed at admission, 3-month reviews and
discharge using the expanded Brief Psychiatric Rating Scale, the Health of the Nation Outcome Scales
and the Kessler 10. Results: Reliable and clinically significant improvement was found for 32.4% of
inpatients on psychiatric symptomatology, 19.5% on psychosocial functioning and 20.2% on
psychological distress. Logistic regression analyses found that the predictor variables collectively
predicted those who made reliable and clinically significant improvement on psychiatric symptomatology,
but not on psychosocial functioning or psychological distress. Those with a primary diagnosis of
schizoaffective disorder had higher rates of improvement in psychiatric symptomatology compared to
those with a diagnosis of schizophrenia. Those with co-morbid substance abuse disorders showed a
trend towards greater improvement. Conclusions: Inpatient treatment is associated with clinically
significant improvements for some patients with a severe mental illness. Patients with schizo-affective
disorders are proportionally more likely to make improvement.
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Objective: The first aim of this study was to assess the proportion of patients who
achieved reliable and clinically significant change over the course of treatment in an
inpatient psychosocial rehabilitation program. The second aim was to determine
whether age, gender, length of stay and diagnoses predicted those who were classified
as improved or not improved, using clinical significance criteria.
Method: Three hundred and thirty-seven patients from inpatient units at Bloomfield
Hospital, Orange, New South Wales, were assessed at admission, 3 month reviews and
discharge using the expanded Brief Psychiatric Rating Scale, the Health of the Nation
Outcome Scales, and the Kessler-10.
Results: Reliable and clinically significant improvement was found for 32.4% of
inpatients on psychiatric symptomatology, 19.5% on psychosocial functioning, and
20.2% on psychological distress. Logistic regression analyses found that the predictor
variables collectively predicted those that made reliable and clinically significant
improvement on psychiatric symptomatology, but not on psychosocial functioning or
psychological distress. Those with a primary diagnosis of schizoaffective disorder had
higher rates of improvement in psychiatric symptomatology compared to those with a
diagnosis of schizophrenia. Those with comorbid substance abuse disorders showed a
trend toward greater improvement.
Conclusions: Inpatient treatment is associated with clinically significant improvements
for some patients with a severe mental illness and those with schizoaffective disorders
are proportionally more likely to make improvement.
Key words: inpatient, clinical significance, severe mental illness, comorbidity
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Severe and persistent mental illnesses are debilitating for the individual and
financially costly for the community (Access Economics, 2002), but there is
considerable support for the benefits of psychosocial interventions to improve a range
of client outcomes (Huxley et al., 2000; Kurtz and Mueser, 2008). Statistical
significance and effect size statistics have frequently been used to describe outcome.
However, more recently the usefulness of reporting clinical significance is being
recognised (Johnson et al., 2006; Lambert and Ogles, 2009). This is because in contrast
to these other methods, clinical significance identifies differences in treatment outcome
for individuals (rather than groups) and provides an indication of whether this change is
clinically meaningful. Whilst multiple methods of measuring clinical significance exist,
the Jacobson and Truax’s (1991) method seems particularly useful for measuring
effectiveness of inpatient programs as it examines whether an individual’s change in
their post-treatment score is a reliable change (i.e. unlikely to be attributable to
measurement error) and whether the post-treatment score reflects a move from the
dysfunctional population to a score more typical of a functional population.
Whilst a number of studies have used clinical significance methods to measure
treatment effectiveness (Bowersox et al., 2009; Glick et al., 1993) only a limited
number of studies have examined this within a psychiatric inpatient population and
report calculated estimates of reliable and clinically significant (RCS) change (e.g.,
Murugesanet al., 2007; Newnham et al., 2007;).
Murugesan et al., (2007) used clinical significance methods to assess outcomes
for people with a schizophrenia spectrum disorder attending a medium length-of-stay
psychosocial rehabilitation program in Australia. RCS improvement was made by 33%
of patients on psychiatric symptomatology, 39% on psychosocial functioning and 21%
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on psychological distress. Murugesan et al., (2007) focused on those with schizophrenia
spectrum disorders, but the units treated patients with a range of other diagnoses and
psychiatric comorbidity. The sample size was not sufficiently large to allow
identification of potential predictors of RCS improvement. For example, people with
comorbid substance abuse in addition to their Axis I diagnosis have been found to be
more difficult to treat and have poorer outcomes (Grella and Stein, 2006) making
comorbidity a potential predictor.
The current study aims to determine the percentage of individuals who show
RCS improvement at the time of discharge from an inpatient rehabilitation program.
Whilst research has examined predictors of outcome among patients with a
schizophrenia spectrum disorder (e.g., Schennach-Wolff et al., 2009), no study appears
to have examined demographic and clinical predictors of treatment outcome, for
psychiatric inpatients with predominantly a schizophrenia spectrum disorder, using
clinical significance criteria to measure outcome. Identification of predictors of RCS
change has various benefits such as the potential to assist with refining treatment. Given
this, the second aim of this study is to explore whether age, gender, length of stay,
diagnosis and comorbid diagnosis predict whether patients show RCS improvements or
not.
Method
Setting and program description
Data were collected from a medium length of stay inpatient rehabilitation
facility (Bloomfield Hospital in Orange, New South Wales). Participants attended either
the 16 bed male or 16 bed female inpatient unit. The mental health team involved in the
program includes a psychiatrist, psychologist, social worker, diversional therapists, an
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occupational therapist, clinical nurse consultant, manager and nursing staff for each
unit. Patients are encouraged to attend groups relevant to them on topics such as drug
and alcohol, medication education or anger management. Care plans are tailored to each
patient. Discharge is planned except on those rare occasions where a patient manages to
abscond.
Admission criteria
Admission criteria for entry into the program remained unchanged since the
previous study (Murugesan et al., 2007). The criteria included a DSM-IV disorder but
excluded individuals with a primary diagnosis of dementia, delirium, substance abuse,
or developmental disorder. Patients who had secondary diagnoses of substance abuse
were admitted. Patients were excluded if they were in an acute phase of their illness
with florid symptoms, and/or those who had an acute physical illness requiring high
levels of nursing care or intensive medical management. Patients who were frequently
aggressive or showed other antisocial behaviours were also excluded. The majority of
patients were involuntarily admitted. The principal reason for admission was for
psychosocial rehabilitation. Patients were frequently admitted for the purposes of
improving their medication adherence and reducing substance abuse.
Participants
The potential participant pool consisted of 371 consecutive patients 18 years and
older who were admitted and discharged between November 2003 and November 2008.
This was a separate group to those previously reported by Murugesan et al., (2007) in
the same programs.
Individuals were excluded from the study if; (a) it was their second admission
during the study period, then data from their second admission were excluded (8
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patients) or (b) admission or discharge data were missing, so change across time could
not be calculated (26 patients). This provided a 91% participation rate overall (n = 337).
There were 170 patients admitted to the male unit and 167 patients admitted to
the female unit over the study period. The mean age at admission of the male
participants was 33.7 years (SD = 9.2 years), with a range of 18-61 years. The mean age
at admission of the female participants was 33.4 years (SD = 10.3 years) with a range of
18-59 years. The mean length of stay for male participants was 109 days, (SD = 61,
range 6-397 days). The mean length of stay for female participants was 113 days (SD =
84, range 15-602 days). Of these female patients, only 4 stayed more than 400 days. The
mean length of stay for the full sample was 111 days (SD = 73 days, median = 91 days).
Patient diagnoses were extracted from medical records. The majority of patients
had a primary diagnosis of schizophrenia (68.0%, n = 229). Schizoaffective disorder
was the next most common diagnosis (20.8%, n = 70). Some patients had another
disorder involving psychosis (6.8%, n = 23). The rest of patients had other diagnoses
(4.5%, n = 15) such as a personality disorder, depression and substance use disorder.
Calculations of comorbid diagnoses revealed 38.0% (n = 128) of patients had a
secondary diagnosis of substance use disorder, 6.5% (n = 22) had an alternative
comorbid disorder and 55.5% (n = 187) had no comorbid diagnosis.
Measures
The measures used in the current study are routinely administered as part of the
national outcome assessment protocols in mental health by the hospital. They are used
for the purposes of planning and monitoring patient care as well as measuring outcome.
Patients have the right to refuse to complete any specific measures.
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The effectiveness of the program was assessed by comparing patient admission
and discharge scores on the measures. These measures were the same as those used in
the study by Murugesan et al., (2007) and are as follows: The Expanded version of the
Brief Psychiatric Rating Scale (BPRS-E; Lukoff et al., 1986), Health of the Nation
Outcome Scales (HoNOS; Wing et al., 1998), and Kessler-10 (K-10; Kessler et al.,
2002).
The BPRS-E is a 24 item measure of psychiatric symptomatology which
involves a structured interview process. It can be divided into four subscales: thought
disturbance, anergia, affect, and disorganisation (Lukoff, et al., 1986). Items are scored
on a rating scale from 1 (not present) to 7 (extremely severe) and then a total score is
calculated. The BPRS-E has good interrater reliability (Ventura et al., 1993).
The HoNOS is a clinician completed 12-item measure of psychosocial
functioning. It covers four domains: behavior (e.g. aggression), impairment (e.g.
cognitive dysfunction), symptoms (e.g. hallucinations), and social functioning (includes
problems with relationships and living conditions) (Wing et al., 1998). Scores for each
item range from 0 (no problem) to 4 (severe to very severe problem). The HoNOS has
good reliability, with an internal consistency of 0.75 (Trauer 1999).
The K-10 is a 10-item self report measure of psychological symptom distress
(Kessler et al., 2003). Respondents are asked “in the past 30 days about how often did
you feel...” various symptoms (e.g. “depressed” and “nervous”). Respondents rate each
item on a 5-point Likert scale which ranges from “none of the time” to “all of the time”.
The K-10 has satisfactory internal reliability as measured by Cronbach alpha (α = .93)
(Kessler et al., 2003).
Procedure
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The research received ethical review and approval from the University of
Wollongong Human Research Ethics Committee. Outcome measures were administered
at admission, discharge and 3 month reviews. The HoNOS was administered by nursing
staff. The K-10 was completed by the patients. Psychologists working at both units
administered the BPRS-E.
Where there was some missing data but over 50% of the scale items were
completed, a prorated score was calculated (proportional average of the available
items). Where less than 50% of items were completed for any measure, this data were
excluded from the analyses. This resulted in six cases being excluded.
Analytic Strategy
Paired samples t-tests determined statistically significant changes over time.
Consistent with the previous study (Murugesan et al., 2007), where discharge data were
not available, scores from the most recent review prior to discharge were used instead.
Means and standard deviations were calculated for admission and review/discharge total
scores on each measure.
Jacobson and Truax’s method was used to calculate clinically significant
change. This method involves calculating reliable change indices using the Christensen
and Mendoza (1986) formula: Reliable Change Index (RCI) = 1.96 × SEdiff.
According to the Jacobson and Truax method, for reliable change to occur, a
patient’s difference in total score from admission to discharge had to be equal to or
greater than the RCI. The SE of measurement of a difference is calculated as: SEdiff =
SD1 × √2 × �(1 − α), where SD1 is the standard deviation of the admission total and α

is Cronbach’s coefficient. Percentages that make reliable change (improvement or
deterioration) were calculated using these methods. To calculate clinical change, three
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different cut-off points needed to be calculated. Clinical change is said to occur if an
individual’s post-treatment score meets the following cut off criteria:
Cut-off 1: More than two standard deviations away from the
dysfunctional population mean.
Cut-off 2: Within two standard deviations of the functional
population mean.
Cut-off 3: Closer to the functional population mean than the dysfunctional
population mean.
Clinical significance cut-off scores were calculated for the three outcome
measures, using the Jacobson and Truax’s (1991) methods. Cut-off 2 and 3 were the
most appropriate for the current sample and enabled comparisons with Murugesan et al.,
(2007). The following formula was used to calculate Cut-off 3:
Cut-off 3=

(meanclin × SDnorm)+ (meannorm × SDclin)
(SDnorm + SDclin)

Meanclin and meannorm are the mean scores of the dysfunctional population, and the
functional population (SD is standard deviation).
A more functional population was considered to be a group with similar
diagnostic characteristics who were able to reside in the community. Functional
population normative data for the BPRS-E were taken from a study which included 43
patients from a community mental health centre and outpatient clinic (Janssen,
Krabbendam et al., 2003). Functional population normative data for the HoNOS were
taken from a study which included a subclinical sample of 1669 patients that came into
contact with a community mental health service (Parabiaghi et al., 2005). Patients were
considered subclinical if they had a score <2 for all HoNOS items. Normative data used
for the BPRS-E and HoNOS were the same as the previous study by Murugesan et al.,
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(2007). For the K-10, normative data from a large representative sample (n = 10641) of
individuals living in the Australian community were used (Andrews and Slade, 2001).
Following calculations of clinically significant improvement, binomial logistic
regression analyses were then conducted using the outcome measures, with the
dichotomous dependent variables of “Reliable and Clinically significantly improved”
versus “Not improved”. Those in the “Not improved” category included those who
made no change and the few patients who also had reliable and clinically significant
deterioration. Patients who were asymptomatic at baseline were not included in
regression analyses since they were by definition not able to make clinically significant
improvement (Bowersox et al., 2009). Age, gender (treatment unit), length of stay,
primary diagnosis and comorbid diagnosis were provided for each patient and
comprised the independent variables.
Since the goal was to predict those that showed RCS improvement we chose cutoff points that produced the largest proportion of improved participants. This was cutoff 2 for the BPRS-E and HoNOS and cut-off 3 for the K10. Primary diagnosis was
categorised into three groups: schizophrenia, schizoaffective disorder, other diagnoses.
Comorbid diagnosis was comprised of three groups, “no comorbid diagnosis”, those
with a secondary diagnosis of substance use disorder (drug and/or alcohol), and “other
comorbid disorders”.
Results
Statistical significance analyses
Paired sample t-tests were computed, comparing means of admission and
discharge scores for all outcome measures (see Table 1). Across all three measures,
overall patients demonstrated significant improvement. There were variations in sample
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sizes for the different outcome measures. The main reason the BPRS-E was not
completed was due to the unavailability of the psychologist to conduct interviews at the
appropriate time. For the HoNOS, noncompletion was due to being overlooked by
staff. For the K-10, this was due to patient refusal.
Insert Table 1 here
Predicting Reliable and Clinically Significant (RCS) change
Psychiatric symptomatology (BPRS-E)
There were 173 complete admission and discharge datasets available for analysis
for the BPRS-E. The RCI was 17.8, which was rounded so that an 18 point change
reflected that reliable change had occurred at the 95% confidence level. Based on this,
84 patients (48.6%) were designated as reliably improved and no patients showed
reliable deterioration. The remaining participants showed no reliable change.
The BPRS-E normative sample mean was 39. Cut-off 2 was calculated as 59.
RCS improvement was made for 62 patients (35.8%). Cut-off 3 was calculated as 52.
RCS improvement was made for 56 patients (32.4%). No patient showed RCS
deterioration, regardless of the cut-off method used.
For the logistic regression Cut-off 2 was selected and the following groups were
obtained: those that made RCS improvement (n = 62) and those that did not (n = 67)
(asymptomatic patients were not included in logistic regressions). The full model
containing all predictors was statistically significant, χ2(n =129) = 19.7, df = 7, p < .05.
The model accounted for 18.9% (Nagelkerke R2) of the total variance, and correctly
classified 69.0% of cases (74.6% correctly classified as no RCS improvement, 62.9%
correctly classified as making RCS improvement). The estimates of the effects of the
predictor variables calculated from the regression are summarized in Table 2. Primary
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diagnosis was a significant predictor and comorbid diagnosis approached significance.
For primary diagnosis, schizophrenia was the reference since this was the most frequent
diagnosis. Those with schizoaffective disorder were 3.5 times more likely to be in the
improved group compared to those with a primary diagnosis of schizophrenia, Exp(β) =
3.52. Although, comorbid diagnosis only approached significance, it suggested that
those with comorbid substance abuse disorders were over two times more likely to be in
the improved group, Exp(β) = 2.29.
In order to check for potential differences between those included in the analysis
(n = 173) and those who did not have pre-post BPRS-E measures (n = 164) we
compared the groups using a series of Chi-square tests. There were no significant
differences between the groups for gender, age, or comorbid diagnosis (p > .05). There
was a significant difference for primary diagnosis, X2(2, N= 337) = 7.18, p < .05. The
only difference was between those with a diagnosis of schizophrenia versus
schizoaffective disorder with a smaller proportion of those included in the analysis
having a diagnosis of schizoaffective disorder (41%) than those excluded from the
analysis (59%), X2(1, N=299) = 4.78, p < .05.
Insert Table 2 about here
Psychosocial functioning (HoNOS)
There were 329 complete admission and discharge datasets available for analysis
for the HoNOS. The RCI for the HoNOS was 10.12 (rounded to 10). Using this RCI a
total of 100 patients (30.4%) made reliable improvement and three patients (.9%)
reliably deteriorated. The remaining participants showed no reliable change. Cut-off 2
was calculated as 6. RCS improvement was made by 75 patients (22.8%). One patient
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made RCS deterioration. Using Cut-off 3 (score of 5), RCS improvement was made by
64 patients (19.5%). One patient made RCS deterioration.
Cut-off 2 was selected for the logistic regression and the following groups were
obtained: those that made RCS improvement (n = 75) and those that did not (n = 220).
The full model was not significant and accounted for only 4.9% of variance (Nagelkerke
R2) χ2(n=295) = 3.3, df = 7, p >.05.
Psychological distress (K10)
There were 258 complete admission and discharge datasets available for analysis
for the K-10. The RCI on the K-10 was 6.9 (rounded to 7). Using this RCI, 83 of the
258 patients (32.2%) were designated as reliably improved and 18 patients (7.0%)
showed reliable deterioration. The remaining participants showed no reliable change.
Cut-off 2 was calculated as 24.3. Given this cut-off is higher than the mean of
admission scores of patients on the K-10 this was not seen as a useful cut-off. Cut-off 3
was calculated as 16.6 (rounded to 17). RCS improvement was made by 52 of 258
patients (20.2%). RCS deterioration occurred for 12 patients (4.7%).
Cut-off 3 was selected for the logistic regression and the following groups were
obtained: those that made RCS improvement (n = 52) and those that did not (n = 94).
The full model was not significant and accounted for 9.3% of variance (Nagelkerke R2)
χ2(n=146) = 10.2, df = 7, p >.05.
Discussion
The reliable change indices (RCI) suggest that between 32% and 49% of
patients make improvement. Further, between 20% and 32% of the patients make both
reliable and clinically significant (RCS) improvements across the three outcome
measures (using cut-off 3). The RCS method is considered a conservative estimate of
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change [29] and in the context of the current study these rates of improvement may be
an underestimate given the most recent 3-month review data were used when discharge
ratings were not available (up to 18% of cases).
Whilst deterioration was generally infrequent, it occurred most on the
psychological distress measure. Anecdotal observations suggest that for some patients
this may occur as a result of increased stress associated with discharge and transition
back into the community.
When compared to the Murugesan et al., (2007) study, which was conducted in
the same treatment facility, there were similar rates of RCS improvement (range 21% to
33% using cut-off 3). Despite the current study having a larger and more diagnostically
diverse group of patients, RCS improvement rates were very similar on the measures of
psychiatric symptomatology and psychological distress. Rates of improvement have
previously been reported on the HoNOS using the RCI for a large sample (n = 21,749)
of adults attending public sector acute inpatient settings across Australia (Burgess et al.,
2009). Using the same criteria as in our study for calculating RCI it was found that 38%
of admission to discharge pairs made improvement. In ambulatory settings only 11.9%
of the 10,354 admission to discharge pairs improved using the RCI. In our study the
equivalent improvement rate using the RCI was 30.4%.
The use of the same performance indicators facilitates comparisons between
areas. Whether this rate of improvement is “satisfactory”, likely depends on the
perspective of different stakeholders. Individuals attending this inpatient setting have
usually exhausted the capacity of public sector acute inpatient services. It is often these
units that refer to the longer stay facilities. Patients are clearly seen as being in need of
further treatment (and supervision) which cannot be provided by other shorter term
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services. Around 25% make clinically meaningful improvement which potentially
increases their capacity to live in less restrictive environments in the community. For
these individuals and their families such outcomes are likely to be viewed positively.
Whether this is “good value for money” can not be determined from our study. Such
questions would ideally be addressed through randomised clinical trials where those
referred to medium term treatment are compared to other forms of rehabilitation (e.g.,
intensive outpatient services).
Sizeable groups appeared to be “asymptomatic” on the measures at admission
when compared to normative samples (HoNOS, 10%; BPRS-E, 25%; K10, 43%). As a
result these participants could not be included in regression analyses that predicted RCS
improvements because by definition they cannot attain this change (Bowersox et al.,
2009). Whether participants appear asymptomatic depends on the normative comparison
group and the outcome variable. For example, the asymptomatic rate for the K10 is
relatively high, but psychological distress is more of a state versus trait construct, and is
relatively transient, thus ratings are likely to vary dependent on recent experiences.
Many patients may not be experiencing acute levels of distress at the time they come
into hospital and to some extent these ratings will depend on how long they have been
in hospital before the intake assessment is completed. In the case of the BPRS-E, the
normative comparison group was a sample of patients still receiving treatment but on an
outpatient basis in the community. Although they could be considered a more
“functional” group overall, they are still likely to be experiencing significant psychiatric
symptoms. Thus, some in our inpatient sample are likely to appear “asymptomatic” in
comparison. It is also possible that some individuals are experiencing specific
behavioural difficulties (e.g., self harm) that mean overall ratings on the measures are
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not elevated (only specific items). Finally, it is possible that an individual could be
considered asymptomatic on one measure, but not on another. Having low levels of
severity in one domain (e.g. psychological distress) does not necessarily mean that there
is good mental health overall.
In addition to determining rates of improvement, a question of equal or more
importance is how might we begin to increase the proportion of people who improve? A
step in this direction involves understanding which factors are related to improvement.
Burgess et al., (2009) argue that, “Expectations of change will also vary within settings,
depending on individual person-based factors such as diagnosis, level of severity of
presenting symptoms and so on”, (p. 537). Our study is one of the first to determine
whether some of the person-based factors are related to RCS change amongst inpatients.
Regression analyses indicated that for psychiatric symptomatology, a significantly
higher proportion of patients with schizoaffective disorder made RCS improvement
relative to those with schizophrenia. This finding is consistent with other research
indicating a more favourable prognosis for people with schizoaffective disorder (Walker
et al., 2004). However, it is unclear why this was only found for psychiatric
symptomatology and not other outcome domains. Firstly, the relationships between the
BPRS-E and other outcome measures at intake and discharge were small to moderate (r
< .26). Thus, they appear to be capturing different outcome domains which could
account for variable prediction. As noted, the transient nature of psychological distress
(K10) may mean that prediction is less reliable using relatively static variables such as
diagnosis. With regard to psychosocial functioning, the HoNOS captures a broad range
of behavioural and social domains but several of the items are unlikely to show any
variability within an inpatient setting (e.g., problems with occupation and activities,
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problems with living condition). A lack of variability and low sensitivity to change has
led others to conclude that the “HoNOS is severely limited in its ability to detect and
record clinically meaningful change” (p. 565) at least in outpatient psychological
treatment (Audin et al., 2001). All of these factors may have contributed to difficulty in
finding reliable predictors on these measures.
Given, some of the logistic regression analyses did not predict RCS change,
further research should examine other potential predictors of RCS change. For example,
there is some evidence to suggest that neurocognitive deficits may be related to outcome
(Green et al., 2000). In addition, more dynamic treatment variables such as medication
adherence or participation in other treatment activities may prove fruitful for predicting
outcomes in the future.
The presence of a comorbid diagnosis of substance abuse approached
significance for predicting RCS changes in psychiatric symptomatology. The superior
improvement rates for those with a comorbid diagnosis of a substance use disorder are
most likely a function of reduced access to alcohol and drugs as a result of being in
residential treatment. The result is notable because treatment outcomes for those with
comorbid substance abuse disorders tend to be poor compared to those without
comorbidity (Turkington et al., 2009).
There is a need to determine whether these initial benefits whilst in residential
care are able to be maintained and built upon once individuals are discharged to
community or less restrictive care. This is particularly important because rates of
community-based treatment have been found to be lower in those with severe mental
illness and co-occurring substance use disorder (Clark et al., 2007). Amongst substance
abusing samples, a comorbid diagnosis of schizophrenia is associated with lower rates
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of attendance in Alcoholics Anonymous compared to those without schizophrenia
(Tomasson and Vaglum, 1998).
In our study one third of those with a diagnosis of schizophrenia also had a
comorbid diagnosis of a substance use disorder. If individuals with severe mental illness
and comorbid substance use disorders are less likely to engage in outpatient treatment
they are potentially at higher risk of relapse. A review of relapse in drug and alcohol use
amongst those with co-occurring mental health and substance use disorders found “no
studies” had examined such relapse amongst those diagnosed with schizophreniaspectrum disorders (Bradizza et al., 2006). Our more recent search also failed to find
any studies that report these relapse rates.
The present study has several limitations. First, a considerable proportion of
patients were considered asymptomatic according to the cut-off points, indicating a high
overlap between “functional” populations and the inpatient population. Although
patients may have low distress scores, they can still have high symptom severity or
functional deficits. They may be asymptomatic on one measure but this does not
automatically mean they have “good” overall mental health. Second, while clinical
significance methods have several advantages, a limitation of using this method is the
lack of appropriate normative data (Lambert and Ogles, 2009). Thirdly, it is difficult to
evaluate the meaning of the RCS rates without a control group or a comparison group
such as other forms of care.
Higher proportions of patients with schizoaffective disorders and those with
comorbid substance use disorders showed RCS improvements in psychiatric
symptomatology compared to those schizophrenia and those with no comorbid
diagnosis. This is encouraging given the difficulty in treating comorbidity in outpatient
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settings, but there is an urgent need to follow patients into the community to assess their
engagement with treatments that address both their mental illness and substance abuse.
Continued assessment of outcomes and drug and alcohol related relapse would also help
inform treatment program development.
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Table 1. Statistically significant changes in outcome measures from admission to
discharge

Measure

na (%)

Admission
M(SD)

Discharge
M(SD)

t

BPRS-E

173 (51.3)

70.38 (16.77)

52.32 (13.35)

16.34***

HoNOS

329 (97.6)

13.49 (5.96)

6.51 (4.27)

18.98***

K-10

258 (76.6)

20.90 (8.81)

16.51 (6.84)

8.67***

a

Number of complete admission and most recent review/discharge datasets available

for analysis. BPRS-E, Expanded Brief Psychiatric Rating Scale; HoNOS, Health of
the Nations Outcome Scales; K-10, Kessler 10. ***p<.001.

Table 2
Binary logistic regression predicting reliable and clinically significant (RCS)
improvement on psychiatric symptomatology (BPRS-E cutoff 2)
Variable

β

SE of β

Exp(β)

95% CI

(Odds ratio)
Age

-.02

-.02

.98

(.94, 1.02)

Gender1

-.61

.41

.54

(.24, 1.22)

Length of stay (days)

-.00

.00

1.00

(.99,1.00)

1.26*

.59

3.52

(1.12,11.18)

.39

.86

1.47

(.27,7.95)

Substance abuse

.83^

.43

2.29

(.99,5.29)

Other disorders

.01

.77

1.01

(.22,4.60)

.93

.93

2.54

Primary diagnosis2
Schizoaffective disorder
Other diagnosis
Comorbid diagnosis3

Constant

Note. * p < .05. ^ p = .053, Dependent variable is 0 = no RCS improvement 1 = RCS
improvement. 10 = female, 1 = male. 2 Schizophrenia is the reference category 3 No
comorbid diagnosis is the reference category

